n-depropylpropafenone has been researched along with Arrhythmias, Cardiac in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Follath, F; Ha, HR; Oti-Amoako, K; Vozeh, S | 1 |
| Brewington, J; Kirsten, EB; Zoble, RG | 1 |
| Kates, RE; Winkle, RA; Yee, YG | 1 |
1 trial(s) available for n-depropylpropafenone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Electrocardiography; Female; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Propafenone; Random Allocation | 1989 |
2 other study(ies) available for n-depropylpropafenone and Arrhythmias, Cardiac
| Article | Year |
|---|---|
The relative potency of major metabolites and enantiomers of propafenone in an experimental reperfusion arrhythmia model.
Topics: Animals; Arrhythmias, Cardiac; Biotransformation; Chromatography, High Pressure Liquid; Male; Myocardial Reperfusion Injury; Propafenone; Rats; Rats, Inbred Strains; Stereoisomerism | 1990 |
Metabolite cumulation during chronic propafenone dosing in arrhythmia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Male; Middle Aged; Propafenone; Propiophenones; Time Factors | 1985 |